Holen Sie sich die Stockscreener-App
281.72
1.91%
5.27
Handel nachbörslich:
282.50
0.78
+0.28%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ELV?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$276.45
Offen:
$275.99
24-Stunden-Volumen:
3.50M
Relative Volume:
1.73
Marktkapitalisierung:
$63.44B
Einnahmen:
$189.25B
Nettoeinkommen (Verlust:
$5.36B
KGV:
11.99
EPS:
23.5
Netto-Cashflow:
$5.34B
1W Leistung:
-16.21%
1M Leistung:
-24.78%
6M Leistung:
-27.90%
1J Leistung:
-44.09%
1-Tages-Spanne:
$275.99
$283.46
1-Wochen-Bereich:
$274.40
$346.36
52-Wochen-Spanne:
$274.40
$567.26
Elevance Health Inc Stock (ELV) Company Profile
Firmenname
Elevance Health Inc
Sektor
Branche
Telefon
(800) 331-1476
Adresse
220 VIRGINIA AVENUE, INDIANAPOLIS
Vergleichen Sie ELV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
281.72 | 75.71B | 189.25B | 5.36B | 5.34B | 23.50 |
|
UNH
Unitedhealth Group Inc
|
285.13 | 264.62B | 410.06B | 22.11B | 24.86B | 23.88 |
|
CI
Cigna Group
|
300.05 | 80.79B | 254.47B | 5.03B | 6.01B | 18.06 |
|
CVS
Cvs Health Corp
|
61.08 | 80.89B | 378.96B | 5.28B | 5.94B | 4.19 |
|
HUM
Humana Inc
|
231.12 | 26.78B | 117.76B | 1.21B | 2.39B | 9.95 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-21 | Herabstufung | Argus | Buy → Hold |
| 2025-07-18 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | Hochstufung | Argus | Hold → Buy |
| 2025-01-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | Herabstufung | Argus | Buy → Hold |
| 2024-07-18 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-06-24 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2023-07-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-03-28 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-08-22 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
Alle ansehen
Elevance Health Inc Aktie (ELV) Neueste Nachrichten
Oscar Health sees full-year loss as ACA market troubles spread - Modern Healthcare
What drives Elevance Health Inc. stock priceSuperior investment outcomes - jammulinksnews.com
Is Elevance Health Inc. a good long term investmentMarket-crushing profits - jammulinksnews.com
Breakthrough: Apple Watch-Based Asthma Program Shows Major Success in Nationwide Clinical Trial - Stock Titan
Barclays Adjusts Elevance Health (ELV) Price Target After Earnin - GuruFocus
What analysts say about Elevance Health Inc. stockDynamic investment growth - jammulinksnews.com
UBS Lowered Firm’s PT on Elevance Health (ELV), Kept a Buy Rating - MSN
Lobbying Update: $1,380,000 of ELEVANCE HEALTH INC. lobbying was just disclosed - Quiver Quantitative
Hedge Fund and Insider Trading News: Bill Ackman, Warren Buffett, Ken Griffin, Neville Shah, Sage Capital, Elevance Health Inc (ELV), NVIDIA Corp (NVDA), and More - Insider Monkey
Elevance Health downgraded at Argus on profit margin pressure - Seeking Alpha
Elevance Health (ELV) Drops 18.66% After Dismal Q2 Earnings - MSN
Elevance Health stock hits 52-week low at 275.6 USD - Investing.com India
Elevance Health, Inc. (ELV): I Won’t Touch It With A 10 Foot Pole, Says Jim Cramer - Insider Monkey
Elevance Health (ELV) Nosedives 12% on Disappointing Q2 - MSN
Elevance Health: the big hit - MarketScreener
Gail Boudreaux Bought 6.0% More Shares In Elevance Health - simplywall.st
Elevance Health, Inc.'s (NYSE:ELV) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong? - Yahoo Finance
Cantor Fitzgerald Reiterates ‘Overweight’ Rating on Elevance Health (ELV) - MSN
Elevance Health, Inc. (NYSE:ELV) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny - 富途牛牛
Elevance Health Inc. (NYSE:ELV) Q2 2025 Earnings Call Transcript - MSN
Elevance Health Inc. Stock Analysis and ForecastPhenomenal wealth increase - jammulinksnews.com
Elevance Health Inc. stock underperforms Friday when compared to competitors - MarketWatch
QuidelOrtho, Acadia Healthcare, Elevance Health, Molina Healthcare, and Alignment Healthcare Stocks Trade Down, What You Need To Know - Yahoo Finance
UBS Adjusts Price Target for Elevance Health (ELV) While Maintai - GuruFocus
UBS Adjusts Price Target for Elevance Health (ELV) While Maintaining Buy Rating | ELV Stock News - GuruFocus
Elevance Health (ELV) CEO Increases Stake with Significant Purchase | ELV Stock News - GuruFocus
Elevance Health Cuts Guidance As Government Business Stumbles - Finimize
Elevance Health Inc (NYSE:ELV) Gave Weak Guidance - FXDailyReport.Com
Elevance Executives Brace for ‘Measurable Last-Chance Uptick’ in Q4 Utilization - Healthcare Innovation
Elevance Health (ELV): Barclays Lowers Price Target | ELV Stock News - GuruFocus
Stocks Pressured by Weakness in Netflix and Health Insurers - Yahoo Finance
Elevance Health: The halt - MarketScreener
Wall Street fears an insurer meltdown is far from over - Modern Healthcare
Elevance Health (ELV) Experiences Significant Decline in Stock V - GuruFocus
Centene, Elevance among Obamacare insurers seeking sharp premium hikes next year: WSJ - MSN
Elevance Health, Inc. (ELV) Stock Forecasts - Yahoo Finance
Elevance Health (ELV) Target Price Reduced Amid Earnings Guidance Concerns | ELV Stock News - GuruFocus
Elevance Health (ELV) Target Price Cut by UBS Analyst | ELV Stock News - GuruFocus
Analyst recommendations: Netflix, Union Pacific, GE Aerospace, Elevance Health, Dell Technologies Ask ChatGPT - MarketScreener
Elevance Health (ELV) Price Target Lowered by Morgan Stanley | E - GuruFocus
This Elevance Health Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga
Elevance Health (ELV) Target Price Lowered by Morgan Stanley | ELV Stock News - GuruFocus
Elevance Health (ELV) Downgraded by Leerink Partners | ELV Stock News - GuruFocus
Elevance Health Inc (ELV) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Cost ... - Yahoo Finance
Elevance Health Inc (ELV) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Cost ... By GuruFocus - Investing.com Canada
Elevance Health (NYSE:ELV) Shares Gap Down Following Weak Earnings - Defense World
Elevance Health: Q2 Earnings Snapshot - The Wilton Bulletin
Decoding Elevance Health Inc (ELV): A Strategic SWOT Insight - GuruFocus
Elevance Health Reports Strong Revenue Growth in Q2 2025 - TipRanks
Elevance Health 2025 Q2 Earnings Misses Targets as Net Income Falls 24.2% - AInvest
Elevance Health Earnings Call: Growth Amid Challenges - TipRanks
Finanzdaten der Elevance Health Inc-Aktie (ELV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.91%
1.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):